Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3440)
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
1,588
Price
$206.89
Total Value
$328.54K
Shares Held After
27,532
% of Holdings
5.5%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
1,457
Price
$205.79
Total Value
$299.84K
Shares Held After
29,120
% of Holdings
4.8%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
743
Price
$204.74
Total Value
$152.13K
Shares Held After
30,577
% of Holdings
2.4%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
668
Price
$203.63
Total Value
$136.02K
Shares Held After
31,320
% of Holdings
2.1%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
697
Price
$202.79
Total Value
$141.34K
Shares Held After
31,988
% of Holdings
2.1%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
950
Price
$201.73
Total Value
$191.64K
Shares Held After
32,685
% of Holdings
2.8%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
698
Price
$201.09
Total Value
$140.36K
Shares Held After
33,635
% of Holdings
2.0%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
53
Price
$200.08
Total Value
$10.60K
Shares Held After
34,333
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
699
Price
$198.71
Total Value
$138.89K
Shares Held After
34,386
% of Holdings
2.0%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
1,142
Price
$208.87
Total Value
$238.53K
Shares Held After
36,869
% of Holdings
3.0%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
1,446
Price
$208.12
Total Value
$300.94K
Shares Held After
38,011
% of Holdings
3.7%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
612
Price
$207.01
Total Value
$126.69K
Shares Held After
39,457
% of Holdings
1.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
340
Price
$206.37
Total Value
$70.16K
Shares Held After
40,069
% of Holdings
0.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
460
Price
$205.18
Total Value
$94.38K
Shares Held After
40,409
% of Holdings
1.1%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
200
Price
$204.17
Total Value
$40.83K
Shares Held After
40,869
% of Holdings
0.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
300
Price
$201.70
Total Value
$60.51K
Shares Held After
41,069
% of Holdings
0.7%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
93
Price
$200.62
Total Value
$18.66K
Shares Held After
41,369
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
207
Price
$199.96
Total Value
$41.39K
Shares Held After
41,462
% of Holdings
0.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
100
Price
$199.00
Total Value
$19.90K
Shares Held After
41,669
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
100
Price
$197.70
Total Value
$19.77K
Shares Held After
41,769
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
920
Price
$266.56
Total Value
$245.23K
Shares Held After
1,475,253
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
2,439
Price
$265.59
Total Value
$647.77K
Shares Held After
1,476,173
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
8,798
Price
$264.85
Total Value
$2.33M
Shares Held After
1,478,612
% of Holdings
0.6%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
2,043
Price
$263.70
Total Value
$538.74K
Shares Held After
1,487,410
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
2,380
Price
$262.44
Total Value
$624.62K
Shares Held After
1,489,453
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
2,962
Price
$261.41
Total Value
$774.29K
Shares Held After
1,491,833
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
3,128
Price
$260.49
Total Value
$814.80K
Shares Held After
1,494,795
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
1,377
Price
$259.87
Total Value
$357.84K
Shares Held After
1,497,923
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
470
Price
$258.38
Total Value
$121.44K
Shares Held After
1,499,300
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
483
Price
$257.31
Total Value
$124.28K
Shares Held After
1,499,770
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,700
Price
$266.42
Total Value
$452.92K
Shares Held After
1,403,155
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
6,000
Price
$265.16
Total Value
$1.59M
Shares Held After
1,404,855
% of Holdings
0.4%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
4,852
Price
$264.64
Total Value
$1.28M
Shares Held After
1,410,855
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
2,248
Price
$263.58
Total Value
$592.53K
Shares Held After
1,415,707
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,938
Price
$262.35
Total Value
$508.43K
Shares Held After
1,417,955
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
2,931
Price
$261.41
Total Value
$766.20K
Shares Held After
1,419,893
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
3,667
Price
$260.37
Total Value
$954.76K
Shares Held After
1,422,824
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
668
Price
$259.61
Total Value
$173.42K
Shares Held After
1,426,491
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
589
Price
$258.54
Total Value
$152.28K
Shares Held After
1,427,159
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
407
Price
$257.32
Total Value
$104.73K
Shares Held After
1,427,748
% of Holdings
0.0%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
14,581
Price
$9.06
Total Value
$132.10K
Shares Held After
660,658
% of Holdings
2.2%
Entrada Therapeutics, Inc. (TRDA)
WENTWORTH KORY JAMES — Chief Financial Officer
Shares
7,988
Price
$12.25
Total Value
$97.89K
Shares Held After
137,987
% of Holdings
5.5%
uniQure N.V. (QURE)
Potts Jeannette — Chief Legal Officer
Shares
3,412
Price
$9.06
Total Value
$30.91K
Shares Held After
138,483
% of Holdings
2.4%
Erasca, Inc. (ERAS)
Morris Shannon — Chief Medical Officer
Shares
20,000
Price
$15.04
Total Value
$300.76K
Shares Held After
0
% of Holdings
100.0%
Olema Pharmaceuticals, Inc. (OLMA)
Mitchell Shawnte — CHIEF LEGAL OFFICER
Shares
233
Price
$24.69
Total Value
$5.75K
Shares Held After
0
% of Holdings
100.0%
Olema Pharmaceuticals, Inc. (OLMA)
Mitchell Shawnte — CHIEF LEGAL OFFICER
Shares
24,767
Price
$24.25
Total Value
$600.60K
Shares Held After
233
% of Holdings
99.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
30,941
Price
$16.60
Total Value
$513.62K
Shares Held After
579,573
% of Holdings
5.1%
LeonaBio, Inc. (LONA)
Renninger Robert — CHIEF FINANCIAL OFFICER
Shares
906
Price
$5.37
Total Value
$4.87K
Shares Held After
15,851
% of Holdings
5.4%
LeonaBio, Inc. (LONA)
Worthington Mark — GENERAL COUNSEL and CCO
Shares
1,328
Price
$5.37
Total Value
$7.13K
Shares Held After
18,376
% of Holdings
6.7%
Bicara Therapeutics Inc. (BCAX)
Hyep Ivan — Chief Financial Officer
Shares
2,963
Price
$18.25
Total Value
$54.06K
Shares Held After
145,355
% of Holdings
2.0%
Showing 801–850 of 3440 transactions (page 17 of 69)